English Bimekizumab Cited by user Ardsnail on 23 Dec 2020 Bimekizumab (INN) is a humanized anti-IL17A and IL-17F monoclonal antibody that is being investigated for ankylosing spondylitis psoriatic arthritis and psoriasis.